The Troubling Legacy of Merck's HPV Vaccines

The vaccine that’s supposed to prevent cancer can actually cause cancer?

Human papillomavirus (HPV) is a prevalent virus that many women encounter at some point in their lives, and there are more than 30 strains of HPV that can cause genital infections. The HPV vaccine is designed to protect against four strains, with only two of them known to be linked to cancer.

Actual complications from the virus are uncommon. Dr. Diane Harper, who participated in HPV vaccine testing during phases II and III, noted that symptoms are typically absent, and the body resolves about 90% of infections within two years. Furthermore, only half of the remaining infections have a slight chance of progressing to precancerous cells that could potentially lead to cervical cancer.

While most cervical cancer cases are HPV-related, most women with HPV do not develop cervical cancer. Nonetheless, Big Pharma advocates for every girl and young woman to receive the vaccine "just in case."

If you have a teenage daughter, her doctor has likely discussed the human papillomavirus (HPV) vaccine with you. They’ll tell you that the studies show it’s “safe and effective” and prevents cervical cancer.

But is this true?

On May 18, 2006, the FDA held a meeting of the “Vaccines and Related Biological Products Advisory Committee” (VRBPAC). We found the summary document on FDA.gov, and at the bottom of page 13, we discovered some important data. Get this! The Gardasil vaccine appears to increase cancer risk by 44.6% in people who are already carriers of the same HPV strains used in the vaccines. Check out the table below.

Isn’t that ironic? The vaccine that’s supposed to prevent cancer can actually cause cancer?

Merck's quadrivalent human papillomavirus (HPV) vaccine, Gardasil, introduced in 2006, has faced significant scrutiny for its safety profile and numerous adverse effects. After Gardasil's introduction in the United States in 2006, a study examining adverse events from 2006 to 2009 uncovered concerning statistics compared to meningococcal vaccination:

• There were 26.5 times more disability events.

• Emergency department visits increased by 8.5 times

• Life-threatening events occurred 10 times more often.

• Hospitalizations were 12.5 times more frequent.

Despite safety concerns raised during clinical trials and mounting reports of horrible adverse reactions, regulatory bodies approved subsequent vaccine versions, including the nine-valent Gardasil 9. These approvals came despite evidence linking Gardasil to serious vaccine injuries and deaths, particularly among young women.

Notwithstanding the mounting evidence indicating injuries linked to the vaccine, the Big Pharma behemoth continues to repeat the biggest lie ever sold and promote Gardasil as "safe and effective." Merck fast-tracked Gardasil's FDA approval process despite failing (and continues to fail) to meet one of the four criteria the FDA requires for fast-track approval. Gardasil is demonstrably neither safer nor more effective than Pap screening combined with the loop electrosurgical excision procedure (LEEP) in preventing cervical cancers, nor can it improve the diagnosis of serious cervical cancer outcomes.

Lawsuits assert that Merck conducted clinical trials deceitfully to hide severe side effects and overstate the vaccine's efficacy. But the FDA wasn’t the only culprit; while Gardasil awaited the CDC's regulatory process, then-director Julie Gerberding facilitated its approval following the drug's FDA authorization in 2006. As a reward, in 2010, she was appointed president of Merck Vaccines. Not surprisingly, according to a 2000 U.S. House of Representatives investigation report, most of the CDC’s eight Committee on Immunization Practices members had conflicts of interest.

Sadly, the same year Gerberding hooked up with Merck, a 16-year-old girl lost her vision completely after HPV vaccination, as reported by the Journal of Child Neurology on Feb. 25, 2010.

The year after Gerberding received her reward, in 2011, a U.S. study uncovered a startling revelation: post-Gardasil Guillain-Barré syndrome (GBS) within six weeks after vaccination was 2.5 to 10 times higher compared to the norm, surpassing rates seen with other vaccines.

In August 2012, Colombia added Gardasil into its national immunization schedule. By August 2014, over 700 girls in El Carmen de Bolivar reported mysterious symptoms following recent Gardasil injections. Here’s a video by Mario Lamo Jimenez, a journalist we interviewed for “The Truth About Vaccines” docu-series, confirming these adverse reactions.

Despite the significant number of severe injuries attributed to the HPV vaccine, a 2019 paper dismissed them as a "mass psychogenic illness." However, how could individuals who are wheelchair-bound, visually impaired, or bedridden not have a genuine illness? These cases are authentic, thoroughly documented, and undeniable.

Then, in 2013, a Danish-Swedish collaboration involving nearly 1 million girls aged 10 to 17 unearthed some eyebrow-raising connections. They found significant links between the HPV vaccine and various ailments, including Behcet’s syndrome (3.37 times more likely), Raynaud’s disease (1.67 times more likely), and Type 1 diabetes (1.29 times more likely).

Fast forward to 2017, when another study involving a whopping 3 million women aged 18 to 44 uncovered a laundry list of adverse events following HPV vaccination, including pemphigus vulgaris, encephalitis, myelitis, Addison’s disease, lupus erythematosus, celiac disease, Raynaud’s disease, and Hashimoto’s thyroiditis.

A 2020 systematic review in Denmark, encompassing 79,102 females and 16,568 males across 24 trials, revealed a 49% elevation in serious nervous system disorders among those administered HPV vaccines compared to “active controls” (which included other vaccines). That’s right! Not compared to a true placebo (like a saline injection), but compared to “active controls” (other vaccines and/or aluminum-based adjuvants). Most control group subjects received a pseudo placebo containing the same aluminum compound as Gardasil. Yet Gardasil still resulted in 49% more adverse effects.

But that’s not all the statistical gimmicks and sleight-of-hand flimflams Merck has used in the past! In scientific research, double-blind placebo trials are widely regarded as the gold standard for evaluating the efficacy and safety of new drugs. These trials aim to minimize bias by randomly assigning participants to either a "treatment" group receiving the drug or a "control" group receiving a pharmacologically inert placebo. Neither the patients nor the researchers know who received the drug or the placebo, reducing the potential for bias in the results.

However, in the case of clinical trials for various HPV vaccines, Big Pharma researchers opted for less rigorous methods and employed tactics to obscure the severity of vaccine-related injuries. Get this! Out of the 16 randomized trials conducted for HPV vaccines, only two utilized an inert saline placebo. Instead, ten of these trials compared the HPV vaccine to a neurotoxic aluminum adjuvant, while four trials used an already-approved vaccine containing aluminum as the comparison. You don’t have to be a rocket scientist to realize that using aluminum-containing placebos will likely muddy the comparison between the treatment and control groups. Talk about scientific shenanigans and trickery!

Another study published in the journal Vaccine comparing nearly 2 million unvaccinated and vaccinated adolescent Columbian girls for the 10-year period 2012 to 2021 revealed that the vaccinated girls were 4.4 times more prone to developing rheumatoid arthritis than their unvaccinated counterparts. During the follow-up period of 180 and 360 days post-vaccination, the girls in the Colombian study were also found to be 2.76 times more prone to developing juvenile idiopathic arthritis, 2.86 times more likely to develop thyrotoxicosis, and 2.54 times more likely to develop idiopathic thrombocytopenic purpura.

In 2022, another Danish study published in the Journal of Autoimmunity provided further evidence linking HPV vaccination to autoimmune responses. The study's authors (Mehlsen et al.) underscore two significant factors that increase the likelihood of HPV vaccines triggering autoimmune responses.

Firstly, the authors emphasized another crucial aspect: specific proteins present in HPV vaccines share similarities with human proteins. In scientific parlance, this phenomenon is termed “molecular mimicry.” According to Yehuda Schoenfeld, an autoimmunity expert, molecular mimicry, mainly when facilitated by potent adjuvants, can instigate immune cross-reactivity, leading to the development of autoimmune diseases.

Secondly, both formulations of Gardasil contain aluminum adjuvants, making them highly immunogenic. These aluminum compounds are deliberately included to stimulate an immune response that might not otherwise occur. According to the CDC’s Vaccine Excipient List, Gardasil's “secret sauce” is aluminum hydroxyphosphate sulfate (AAHS). Shockingly, this “proprietary” ingredient from Merck has never been tested for safety in humans.

Nevertheless, despite the lack of safety testing and the destruction, deaths, and damage, Merck unveiled two fresh strategies earlier this month to expand the worldwide market for its HPV vaccines, including their initial single-dose HPV injections and multivalent HPV vaccines tailored for Asian and African populations. If you’re wondering why Merck would continue pushing Gardasil despite the damage, look no further than their financial statements. In 2023, Merck’s reported global profits from Gardasil increased 29% over 2022 to a whopping $8.9 billion!

In total, Merck is currently contending with 140 lawsuits in federal court filed by individuals who experienced various severe injuries following Gardasil administration. One of the lawsuits alleges Gardasil caused a 13-year-old boy’s death. Side effects (which are actually direct effects of the vaccine) include premature ovarian failure, autoimmune and neurological conditions like postural orthostatic tachycardia syndrome (POTS), fibromyalgia, encephalomyelitis, chronic fatigue syndrome, and cancer. Additionally, more than 200 pending claims are related to Gardasil injuries in the Vaccine Court.

The data indicate that countries with high Gardasil adoption rates also exhibit higher cancer rates among younger women. In contrast, older women adhering to the Pap test regimen but not receiving vaccination demonstrate decreased rates.

Despite this, Merck persists in promoting the vaccine for children, claiming it provides protection against future cancers. Furthermore, Merck-funded researchers are still exploring methods to enhance vaccination rates among children.

Fortunately, it appears that the public is becoming increasingly aware of the deception and fraud surrounding the HPV vaccine. However, this increased awareness does little to help the tens of thousands of young women (and men) across the globe who have already been affected by Gardasil.

According to reports from the Vaccine Adverse Event Reporting System (VAERS), over 44,000 cases of adverse events had been reported as of mid-March 2024, with tens of thousands more injuries likely going unreported.